Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases  by Stone, James R. et al.
Cardiovascular Pathology 24 (2015) 267–278
Contents lists available at ScienceDirect
Cardiovascular PathologyReview ArticleConsensus statement on surgical pathology of the aorta from the Society
for Cardiovascular Pathology and the Association for European Cardio-
vascular Pathology: I. Inﬂammatory diseasesJames R. Stone a,⁎, Patrick Bruneval b,⁎⁎, Annalisa Angelini c, Giovanni Bartoloni d, Cristina Basso c,
Lubov Batoroeva e, L. Maximilian Buja f, Jagdish Butany g, Giulia d'Amati h, John T. Fallon i,
Adriana C. Gittenberger-de Groot j, Rosa H. Gouveia k, Marc K. Halushka l, Karen L. Kelly m, Ivana Kholova n,
Ornella Leone o, Silvio H. Litovsky p, Joseph J. Maleszewski q, Dylan V. Miller r, Richard N. Mitchell s,
Stephen D. Preston t, Angela Pucci u, Stanley J. Radio v, E. Rene Rodriguez w, Mary N. Sheppard x,
S. Kim Suvarna y, Carmela D. Tan w, Gaetano Thiene c, Allard C. van der Wal z, John P. Veinot aa
a Massachusetts General Hospital, Boston, MA, USA
b University Paris-Descartes, France
c University of Padua Medical School, Padua, Italy
d University of Catania, Catania, Italy
e Russian Academy of Medical Sciences, Irkutsk, Russia
f University of Texas Health Science Center at Houston, Houston, TX, USA
g Toronto General Hospital, Toronto, Canada
h Sapienza, University of Rome, Rome, Italy
i New York Medical College, Valhalla, NY, USA
j Leiden University, Leiden, the Netherlands
k Hospital Santa Cruz, Carnaxide, Portugal
l Johns Hopkins University, Baltimore, MD, USA
m East Carolina University, Greenville, NC, USA
n Fimlab Laboratories, Tampere, Finland
o Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
p University of Alabama at Birmingham, Birmingham AL, USA
q Mayo Clinic, Rochester, MN, USA
r University of Utah, UT, USA
s Brigham and Women’s Hospital, Boston, MA, USA
t Papworth Hospital, Cambridgeshire, UK
u Pisa University Hospital, Pisa, Italy
v University of Nebraska, NE, USA
w Cleveland Clinic, Cleveland, OH, USA
x St George Medical School, University of London, London, UK
y Shefﬁeld Teaching Hospitals, Shefﬁeld, UK
z University of Amsterdam, Amsterdam, the Netherlands
aa University of Ottawa, Ottawa, Ontario, Canada
a b s t r a c ta r t i c l e i n f oThere were no sources of external funding.
⁎ Correspondence to: J.R. Stone, Massachusetts General
⁎⁎ Correspondence to: P. Bruneval, Department of Patholo
E-mail addresses: jrstone@partners.org (J.R. Stone), pa
http://dx.doi.org/10.1016/j.carpath.2015.05.001
1054-8807/© 2015 Elsevier Inc. All rights reserved.Article history:
Received 23 March 2015
Received in revised form 11 May 2015
Accepted 11 May 2015Inﬂammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and atherosclerosis with
excessive inﬂammatory responses, such as inﬂammatory atherosclerotic aneurysms. The nomenclature and his-
tologic features of these disorders are reviewed and discussed. In addition, diagnostic criteria are provided to dis-
tinguish between these disorders in surgical pathology specimens. An initial classiﬁcation scheme is provided for
aortitis and periaortitis based on the pattern of the inﬂammatory inﬁltrate: granulomatous/giant cell pattern,Hospital, Simches Building Room 8236, Boston, MA, USA 02114. Tel.: +1 617 726 8303; fax: +1 617 643 3566.
gy Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015, Paris, France. Tel.: +33 1 56 09 38 60; fax: +33 1 56 09 38 89.
trick.bruneval@egp.aphp.fr (P. Bruneval).
268 J.R. Stone et al. / Cardiovascular Pathology 24 (2015) 267–278Keywords:
Atherosclerosis
Aortitis
Inﬂammatory aneurysm
Aortalymphoplasmacytic pattern, mixed inﬂammatory pattern, and the suppurative pattern. These inﬂammatory
patterns are discussed in relation to speciﬁc systemic diseases including giant cell arteritis, Takayasu arteritis,
granulomatosis with polyangiitis (Wegener’s), rheumatoid arthritis, sarcoidosis, ankylosing spondylitis, Cogan
syndrome, Behçet’s disease, relapsing polychondritis, syphilitic aortitis, and bacterial and fungal infections.© 2015 Elsevier Inc. All rights reserved.1. Introduction
Aortic diseases cause signiﬁcant morbidity and mortality through
the development of aneurysm, aortic wall rupture, acute dissection,
and luminal obstruction [1,2]. These phenomena can result from many
distinct diseases that afﬂict the aorta. During surgical repair of aortic an-
eurysms and dissections, portions of aorta resected by surgeons contain
important diagnostic information concerning these underlying diseases.
To promote a better understanding of these aortic diseases and to en-
hance patient care, the Standards and Deﬁnitions Committee of the So-
ciety of Cardiovascular Pathology and the Association for European
Cardiovascular Pathology is issuing guidelines for diagnosing aortic dis-
eases in surgical pathology specimens. These guidelineswill be issued in
two consecutive reports. Thisﬁrst report on aortic diseaseswill cover in-
ﬂammatory diseases of the aorta, with other aortic diseases being ad-
dressed in a second document.
This document on surgical aortic diseases will cover atherosclerosis,
inﬂammatory atherosclerotic aneurysms (IAAs), aortitis, and
periaortitis. Including atherosclerosis as an inﬂammatory aortic disease
is not a declaration that inﬂammation is the underlying driving force for
all atherosclerosis. It is acknowledged that atherosclerosis is usually as-
sociated with inﬂammation but has multiple precipitating etiological
factors in addition to inﬂammation including age, lipid metabolism,
and vascular cell activation. The inﬂux of lipid into the vessel wall is a
key feature in the development of atherosclerosis [3,4], and the inﬂam-
mation present is usually a reaction to this lipid. However, in atheroscle-
rosis, the degree of the inﬂammatory reaction can be substantial, and in
some cases, the inﬂammation can contribute to complications such as
aneurysm formation and surface disruption with thrombus formation,
justifying the inclusion of atherosclerosis as an inﬂammatory aortic dis-
ease. It is acknowledged that many primarily noninﬂammatory aortic
diseases to be covered in the subsequent report are associated with
some degree of inﬂammation, although in those disorders, the inﬂam-
mation is usually mild and occurs secondarily to some other primary
pathologic process. Disorders of the aortic valve will not be covered in
this report.
It is understood that precise classiﬁcation of an inﬂammatory aortic
disease may require correlation of the pathologic features with clinical
features, other laboratory ﬁndings, and imaging. Thus, there are two
major sections to this report. First, there is a section focusing on a
histology-based classiﬁcation scheme, with recommendations for no-
menclature and diagnostic criteria, to aid the surgical pathologist
when confronted with one of these specimens, following which there
is a section discussing the pathology of the speciﬁc inﬂammatory aortic
disorders. In both of these sections, the disorders are discussed in order
of increasing amounts of inﬂammation, starting with atherosclerosis,
which has variable amounts of inﬂammation, and ending with aortitis,
which is deﬁned by the presence of more extensive inﬂammation. The
committee supports speciﬁc training in cardiovascular pathology [5]
and the speciﬁc involvement of cardiovascular pathologists in thework-
up of complex aortic surgical pathology specimens.
2. Methods
Consensus committee membership was solicited from members of
the Society for Cardiovascular Pathology and the Association for
European Cardiovascular Pathology. This multi-institutional committee
membership identiﬁed the types of inﬂammatory aortic diseasesencountered by cardiovascular surgical pathology services, reviewed
the literature on these conditions, and constructed consensus guidelines
for nomenclature and diagnostic criteria. For this report, consensus is
deﬁned as being the majority of the membership of the committee
and may not necessarily, in all cases, indicate a unanimous opinion.
The opinions put forth here do not necessarily represent the opinions
of all members of the Society for Cardiovascular Pathology or the Asso-
ciation for European Cardiovascular Pathology. Areas with signiﬁcant
dissenting opinion within the committee are indicated in the text. For
the consensus opinions, an emphasis was placed on incorporating the
results of relevant published peer-reviewed literature.
3. Histologic classiﬁcation and diagnostic criteria of inﬂammatory
aortic diseases
3.1. Processing of aortic surgical pathology specimens
It is recommended to examine the aortic specimen grossly and to
measure both the overall dimensions of the specimen and thickness of
the aortic wall. It is recommended to note the presence and extent of
atherosclerotic lesions as well as features suggestive of aortitis, includ-
ing thickening of the wall and cracking/wrinkling of the intima, i.e., a
“tree bark” appearance. In accordance with previous consensus guide-
lines, it is recommended that all segments of aorta surgically resected
for aneurysm or dissection be examined histologically [6]. In the ab-
sence of a clinical history of vasculitis or gross ﬁndings suggestive of
aortitis, it is recommended that six pieces of aorta be submitted in a
total of two cassettes for initial screening. If there is a clinical history
of vasculitis, gross ﬁndings worrisome for aortitis, or histologic ﬁndings
suggesting aortitis, then it is recommended to submit additional blocks
of tissue for histologic examination. In these situations, it is recom-
mended to submit up to 12 blocks of tissue, or at least 1 block of tissue
per cm of tissue, to fully characterize the nature of the inﬂammatory in-
ﬁltrate. Sections are recommended to be 1.0–1.5 cm in length and cut in
cross section, i.e., perpendicular to the longitudinal axis of the aorta. If
atherosclerosis is present, it is recommended to submit both areas
with andwithout atherosclerosis. If there is a clinical history of infection
or a grossly suppurative appearance, i.e., pus, and tissuewas not sent for
culture directly from the operating room, then it is recommended to
send fresh sterile tissue for culture if possible. Fresh sterile tissue can
also be frozen for potential use in identiﬁcation of microorganisms by
ribosomal DNA ampliﬁcation and sequencing. Hematoxylin and eosin
(H&E) and elastic stains should be evaluated. Trichrome (or Azan–
Mallory or Sirius red),Movat, andAlcian–PAS stains are helpful to identify
areas of degeneration, elasticﬁber fragmentation, scarring, and accumula-
tion of proteoglycans and mucopolysaccharides. Immunohistochemical
staining forα-smoothmuscle actin can also be helpful in assessing the in-
tegrity of medial smooth muscle cells.
3.2. Major diagnostic classes of inﬂammatory aortic diseases
The committee recognizes that there are three broad categories of
inﬂammatory aortic disease, which in order of increasing inﬂammation
are atherosclerosis, atherosclerosis with excessive inﬂammation, and
aortitis/periaortitis (Table 1). Speciﬁc aortic diseases are described in
more detail in Section 4. Atherosclerosis is most often associated with
at least some degree of inﬂammation, and in some cases, the inﬂamma-
tion can be prominent. It is also acknowledged that some patients show
Table 1
Comparison of major diagnostic classes of inﬂammatory aortic diseases
Diagnostic class Degree, location, and type of
inﬂammation in relation to the
degree of atherosclerosis present
Examples
Atherosclerosis Routine for atherosclerosis Atheroma,
ﬁbroatheroma, thin-cap
ﬁbroatheroma
Atherosclerosis
with excessive
inﬂammation
Uncommon for atherosclerosis but
likely due to atherosclerosis
IAA, atherosclerosis with
excessive neutrophilc
inﬂammation
Aortitis/
periaortitis
Cannot be accounted for by
atherosclerosis.
Infectious aortitis/
periaortitis,
noninfectious aortitis/
periaortitis
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to a vessel with atherosclerosis. Since these cases may be associated
with distinct clinical features, the committee recommends highlighting
these cases with the designation of atherosclerosis with excessive in-
ﬂammation. The committee also recommends reserving the designa-
tions aortitis and periaortitis for inﬂammatory aortic conditions in
which the inﬂammation cannot be fully accounted for solely by
atherosclerosis.
3.3. Atherosclerosis
Multiple detailed classiﬁcation schemes for atherosclerosis have
been reported [7–11]. These schemes have much utility in research
studies, particularly of the coronary arteries. However, these schemes
have severe limitations in the setting of aortic surgical pathology. First,
there are little to no data to indicate that all of the speciﬁc categories
in these schemes have clinical signiﬁcance for aortic disease. Also,
these schemes are largely based on intimal changes, and many clinical
complications of aortic atherosclerosis, such as aortic aneurysm forma-
tion, are largely based on changes in the media. In essence, these
schemes do not readily delineate when atherosclerosis is the primary
aortic pathology or when the atherosclerosis is superimposed on a
more signiﬁcant underlyingdisorder such as a connective tissue disease.
Thus, it is recommended that a simpliﬁed and more directly relevantTable 2
Grading atherosclerosis in surgically resected segments of aorta
Grade/qualiﬁer Gross Histology
No signiﬁcant
atherosclerosis
Normal or fatty
streaks
Intimal thickening/hyperplasia
Scattered intimal foam cells and
lymphocytes
Mild atherosclerosis Raised plaques Extracellular lipid deposition
without ﬁbrosis (AHA grade III/IV
[8,9])
Minimal to no destruction or loss
of media
Moderate atherosclerosis Raised or
conﬂuent
plaques
Extracellular lipid deposition with
ﬁbrosis
(AHA grade V and above [9])
Destruction or loss of less than 1/3
of the media thickness
Severe atherosclerosis Raised or
conﬂuent
plaques
Extracellular lipid deposition with
ﬁbrosis
(AHA grade V and above [9])
Destruction or loss of 1/3 or more
of the media thickness
Atherosclerosis with
plaque disruption and
surface thrombusa
Ulcerated plaque
with surface
thrombus
Atherosclerotic plaque (AHA grade
III and above [8,9]) with surface
disruption and surface thrombus
Calciﬁc atherosclerosisa Firm calciﬁed
plaque
Atherosclerotic plaque (AHA grade
III and above [8,9]) with
calciﬁcation.
AHA, American Heart Association.
a Used in conjunction with the grade mild, moderate, or severe.atherosclerosis classiﬁcation scheme be employed for aortic surgical pa-
thology (Table 2). This simpliﬁed scheme is based on designating ath-
erosclerosis as mild, moderate, or severe based largely on the presence
of ﬁbrosis and the amount of medial loss or destruction due to the ath-
erosclerosis (Fig. 1). A designation of severe atherosclerosis would indi-
cate a degree of the disease for which the atherosclerosis may be the
predominant pathologic feature in the specimen. The scheme also spec-
iﬁes for the pathologist to indicate the presence of plaque disruption
and luminal thrombus. Such luminal thrombus can be associated with
any degree of atherosclerosis, mild, moderate, or severe, and the pres-
ence of such thrombus has important clinical implications for embolic
ischemic events. The scheme also allows the pathologist to designate
if the plaque is calciﬁed. The overall extent of atherosclerosis is best ob-
tained from the gross inspection of the aorta and can be described as
focal, patchy, or diffuse.
The inﬂammation in atherosclerotic lesions consists primarily of
macrophages in the intima. There may also be lymphocytes present in
the intima, media, and/or adventitia, which are primarily CD3+ T-
cells, although, in some cases, nodular aggregates of CD20+ B-cells
will be present in the adventitia along with clusters of plasma cells.
Disrupted plaques will show surface thrombus, and chronically
disrupted or ulcerated plaques may contain organizing thrombus.
Giant cells reacting to cholesterol clefts may be present. In disrupted
plaques, neutrophils are often present near the site of disruption.
3.4. Atherosclerosis with excessive inﬂammation
In some cases, the degree of inﬂammatory reaction in a vessel with
moderate to severe atherosclerosis is unusually intense but can still be
explained as a reaction to the atherosclerotic plaque. Two major exam-
ples of this phenomenon are atherosclerosiswith excessive neutrophilic
inﬂammation and IAA (Fig. 2). Between “usual atherosclerosis” andFig. 1. Grades of Atherosclerosis. (A) No signiﬁcant atherosclerosis. (B) Mild atherosclero-
sis. (C) Moderate calciﬁc atherosclerosis. (D) Severe atherosclerosis with plaque disrup-
tion and surface thrombus.
Fig. 2. Atherosclerosis with excessive inﬂammation. (A) IAA. (B) Atherosclerosis with ex-
cessive neutrophilic inﬁltrates.
Table 3
Inﬂammatory patterns in aortitis and periaortitis
Inﬂammatory
pattern
Composition Examples of speciﬁc
systemic diseases
Granulomatous/
giant cell pattern
Clusters of epithelioid
macrophages with or
without giant cells or
compact/well-formed
granulomas
Usually without compact/
well-formed granulomas:
GCA, GPA, EGPA
Sometimes with compact/
well-formed granulomas:
Rheumatoid arthritis,
Takayasu arteritis
Usually with compact/well-
formed granulomas:
Sarcoidosis, mycobacterial
and fungal infections
Lymphoplasmacytic
pattern
Lymphocytes and plasma
cells without a
granulomatous component
IgG4-RD, lupus, AS, syphilitic
aortitis, an undersampled
granulomatous aortitis
Mixed
inﬂammatory
pattern
All/most inﬂammatory cell
types without an overt
granulomatous pattern
Cogan syndrome, Behçet’s
disease, relapsing
polychondritis
Suppurative
pattern
Neutrophilic abscesses with
necrosis and cell debris
Staphylococcus,
Streptococcus, Salmonella,
Pseudomonas, and fungal
infections
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degrees of inﬂammation may be associated with aortic atherosclerosis.
3.4.1. Atherosclerosis with excessive neutrophilic inﬂammation
This is an unusual condition inwhich there is an excessive amount of
neutrophils involving an atherosclerotic plaque, often in the setting of
plaque disruption and luminal thrombus formation [12]. The primary
entity in the differential is suppurative aortitis due to bacterial infection.
In contrast to suppurative aortitis, extensive necrosis is not present
other than in the necrotic/lipid atherosclerotic core. Also, microorgan-
isms are not present on special stains. If considering this diagnosis, it
is recommended that Gram, Grocott–Gomori methenamine silver and
a silver impregnation stain such as Steiner or Warthin–Starry be evalu-
ated to assess for infectious agents. It may not be possible to deﬁnitively
rule out infection in such cases.
3.4.2. Inﬂammatory atherosclerotic aneurysm
IAA is associated with severe atherosclerosis and is thus most com-
mon in the abdominal aorta. The committee recommends the term in-
ﬂammatory atherosclerotic aneurysm over inﬂammatory aortic
aneurysm to emphasize the relationship with atherosclerosis, to allow
for future inclusion of similar pathologies outside of the aorta, and to
promote a clearer distinction from aortitis and periaortitis. Histological-
ly, IAA shows the features of severe atherosclerosis with an excessive
degree of adventitial inﬂammation. The adventitial inﬂammation con-
sists primarily of lymphocytes and plasma cells. Eosinophils may also
be present. It is recommended that, for a pathologic diagnosis of IAA,
the thickness of the aortic wall exceeds 4 mm [13]. The primary entity
in the differential is periaortitis. It is acknowledged that, currently,
criteria for distinguishing IAA from periaortitis have not been fully de-
veloped. However, the presence of pathologic features in the adventitial
inﬂammation that are not typical of atherosclerosis would favor
periaortitis. Such features would include compact granulomas, exten-
sive IgG4+plasma cells, a suppurate pattern of inﬂammation, or exten-
sive necrosis. The presence of intense adventitial inﬂammation with no
signiﬁcant ormild atherosclerosiswould also favor periaortitis over IAA.
3.5. Aortitis and periaortitis
With the advent of newer biologic therapies that target speciﬁc in-
ﬂammatorymolecules such as tumor necrosis factor-α, CD20, and inter-
leukin (IL)-6, therapies for aortitis are becoming more tailored to the
speciﬁc type of aortitis present [14,15]. Thus, correct subclassiﬁcation
of aortitis is becoming increasingly more important. Subclassiﬁcation
of aortitis often requires a combination of clinical, radiologic, laboratory,
and pathologic information. Therefore, when confronted with a case ofaortitis, it is recommended that the surgical pathologist review the clin-
ical, radiologic, and laboratory ﬁndings when possible. It is recognized
that, in many cases, complete classiﬁcation of aortitis to a speciﬁc dis-
ease process is not possible. However, it is recommended that the
aortitis be primarily subclassiﬁed pathologically based on the pattern
of the inﬂammatory inﬁltrate (Table 3). The differential diagnosis
concerning speciﬁc diseases can be discussed in a note or comment in
the surgical pathology report. The presence of necrosis can also be indi-
cated. It is helpful to acknowledge in the note that, in some patients
with aortitis, the clinically apparent manifestations of their vasculitis
may be limited to the aorta. If the inﬂammation is restricted to the ad-
ventitia, the term periaortitis is recommended. If the inﬂammation in-
volves the media and/or intima to any degree, then the term aortitis is
recommended. The committee supports the Chapel Hill consensus
criteria for the general classiﬁcation of vasculitis [16].3.5.1. Aortitis/periaortitis with granulomatous/giant cell pattern
A granulomatous/giant cell pattern is the most common pattern of
inﬂammation in aortitis. The granulomatous/giant cell pattern consists
of clusters of activated epithelioid macrophages (Fig. 3). Giant cells
and/or actual granulomas may also be present. A lymphoplasmacytic
component will also usually be present in the adventitia and/or the
media. Pathologic features of the inﬂammation can help delineate the
underlying speciﬁc disease. The presence of extensive non-necrotizing
compact/well-formed granulomas would suggest sarcoidosis. The pres-
ence of necrotizing granulomas would suggest rheumatoid vasculitis,
Takayasu aortitis, mycobacterial infection, or fungal infection. It is rec-
ommended to obtain stains for microorganisms in such cases. As
discussed inmore detail below, comparedwith Takayasu arteritis, aortic
involvement by giant cell arteritis (GCA) tends to show less adventitial
scarring and a predilection for the inner half of the media (Fig. 4,
Table 4). Extensive neutrophils and geographic necrosis would support
involvement by granulomatosis with polyangiitis (GPA).
The committee recognizes that the term giant cell aortitis is being ap-
plied in different manners in different medical centers. It is recognized
that the term is often used to suggest involvement of the aorta by GCA
(Horton’s disease) (Table 5). Thus, it is recommended that the term
not be used liberally for any aortitis containing giant cells, particularly
if there are clinical or pathologic features to suggest a disorder distinct
from GCA.
Fig. 3. Inﬂammatory patterns for aortitis and periaortitis. (A–C) The granulomatous/giant cell pattern is comprised of clusters of epithelioid macrophages (A), giant cells (B), and/or
compact well-formed granulomas (C). (D) Lymphoplasmacytic pattern. (E) Mixed inﬂammatory pattern. (F) Suppurative pattern.
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In the lymphoplasmacytic pattern of aortitis, the inﬂammation is
composed of lymphocytes and plasma cells without a granulomatous
component. The lymphoplasmacytic pattern is much less common
than the granulomatous/giant cell pattern in most populations studied.
It is recommended to stain such cases for IgG4 and either IgG or CD138.
A primary speciﬁc disease to consider when confronted with this pat-
tern of inﬂammation is IgG4-related disease (IgG4-RD). By international
consensus criteria, thepresence ofmore than 50 IgG4+plasma cells per
400x high power ﬁeld (HPF) with more than 50% of the IgG+ plasma
cells expressing IgG4 would support the presence of IgG4-related
aortitis. At least three 400× HPFs should be assessed. The diagnosis of
IgG4-related aortitis also requires the absence of another inﬂammatory
process, such as infection or granulomatous inﬂammation. In
lymphoplasmacytic aortitis cases, a special stain for spirochetes can be
obtained, particularly if there is a clinical history of syphilis, but such
stains are rarely rewarding in this setting.
3.5.3. Aortitis/periaortitis with mixed inﬂammatory pattern
The mixed inﬂammatory pattern is a relatively uncommon type of
aortitis. The inﬂammatory inﬁltrate will contain substantial quantities
of most, if not all, inﬂammatory cell types: macrophages, lymphocytes,
plasma cells, eosinophils, mast cells, and neutrophils. An overtlygranulomatous pattern of inﬂammation is not present in these cases,
but necrosis may be present. This inﬂammatory pattern has been asso-
ciated with aortitis in Cogan syndrome, Behçet’s disease, and relapsing
polychondritis. The latter two conditions have also been linked together
clinically in some cases as the MAGIC (Mouth And Genital ulcers with
Inﬂamed Cartilage) syndrome [17].
3.5.4. Aortitis/periaortitis with suppurative pattern
In the suppurative pattern of aortitis, there is a marked neutrophilic
inﬁltrate with extensive necrosis histologically. This pattern is largely
associatedwith bacterial infection and, in some cases, with fungal infec-
tion. Special stains for microorganisms are recommended, as discussed
in detail in Section 4.3 below. Focal granulomatous reaction to the or-
ganisms may also be present. In the chronic stages, ﬁbrosis and
lymphoplasmacytic inﬁltrates may be present. In chronic active infec-
tions from Gram-positive bacteria, the plasma cells may show focally
high expression of IgG4. However, the presence of the coexisting suppu-
rative pattern and bacteria enables distinction from IgG4-related
aortitis.
3.5.5. Unclassiﬁed aortitis/periaortitis
An aortitis/periaortitis that does not ﬁt readily into one of the above
designations can be designated as unclassiﬁed aortitis/periaortitis. In
Fig. 4. Comparison of GCAwith Takayasu Arteritis. The aortitis in GCA (A) tends to involve
the inner half of the media most severely with less adventitial involvement and with usu-
ally no compact/well-formed granulomas. In contrast, the aortitis in Takayasu arteritis
(B) tends to show more adventitial involvement and may contain compact/well-formed
granulomas. At highermagniﬁcation, the aortitis inGCA contains epithelioidmacrophages
and often giant cells (C), while, in addition to these features, compact granulomas may
also be present in Takayasu arteritis (D).
Table 5
Eponyms and historical nomenclature for selected inﬂammatory aortic diseases
Disease Eponyms and historical nomenclature
GCA Horton’s disease, cranial arteritis, giant cell aortitis,
granulomatous arteritis, polymyalgia arteritis, temporal arteritis
Takayasu
arteritis
Aortic arch syndrome, idiopathic arteritis, Martorell syndrome,
nonspeciﬁc aortoarteritis, obliterative brachiocephalic arteritis,
occlusive thromboaortopathy, panaortitis or aortitis syndrome,
pulseless disease, reversed coarctation, Takayasu's disease,
Takayasu syndrome, young female arteritis
GPA Wegener’s granulomatosis, pathergic granulomatosis, ANCA-
associated granulomatous vasculitis
EGPA Churg Strauss syndrome, allergic granulomatous vasculitis
Behçet’s
disease
Adamantiades–Behçet’s disease, Behçet’s syndrome, Silk Road
disease
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ﬁltrate be described, including the types of inﬂammatory cells present
and the presence and extent of necrosis and scarring.
4. Inﬂammatory diseases of the aorta
4.1. Atherosclerosis
Atherosclerosis is a disease characterized by the formation of intimal
plaques containing smooth muscle cells, myoﬁbroblasts, lipid, collagen,Table 4
Comparison of GCA and Takayasu arteritis
GCA Takayasu arteritis
Age Usually N 50 years Usually b50 years
Most severely
afﬂicted race
Northern European Asian
Arteries involved Aorta, proximal branches,
cranial arteries
Aorta, proximal branches,
pulmonary arteries
Aortic layers
involved
Inner media N outer media
and adventitia
Outer media and adventitia N
inner media
Compact
granulomas
Usually absent May be presentand/or calciﬁcation with variable amounts of inﬂammation in large and
medium-sized arteries. The inﬂammation in atherosclerosis is com-
posed predominantly of macrophages/foam cells, which release metal-
loproteinases. Atherosclerosis has several predilection sites, and the
aorta, particularly the abdominal aorta, is one of the sites that is affected
early and often severely during the course of the disease. The pathologic
characteristics of aortic atherosclerosis have been described extensively
in numerous postmortem studies [18–25]. The disease begins, often in
childhood, with hyperplastic thickening of the intima due to accumula-
tion of smooth muscle cells. Lipid is entrapped within the thickened in-
tima and ingested by macrophages and to a lesser extent smooth
muscle cells to become foam cells. Continued lipid deposition results
in extracellular lipid accumulation and eventually a central necrotic/
lipid core composed of lipid and debris from dead macrophages and
smoothmuscle cells. The development of atherosclerotic lesions is asso-
ciated with varying degrees of ﬁbrosis, calciﬁcation, and inﬂammatory
reactions.With lesion progression, there are progressive elastic lamellae
fragmentation, thinning, and ﬁbrosis of the medial layer, with variable
ﬁbrosis and inﬂammation of periadventitial tissues. Severe aortic ath-
erosclerotic plaques frequently show disruption of the plaque surface
or “ulceration” with adherent organizing thrombus.
While atherosclerosis usually starts in childhood, the rate of progres-
sion of atherosclerotic plaques depends on both genetic factors and
nongenetic risk factors such as hypercholesterolemia, systemic arterial
hypertension, diabetes mellitus, smoking, obesity, and aging. In the
aorta, plaque formation can be seen in its earliest stages in the posterior
aortic wall, especially around ostia of branch vessels. In the advanced
stages, usually in the elderly population, diffuse involvement of large
segments of the aorta can be seen, particularly in the infrarenal aorta.
There is often amarked difference in disease severity between the high-
ly atherosclerosis-prone abdominal aorta and the less atherosclerosis-
prone thoracic aorta. In addition, thepresence of atherosclerotic plaques
and the relative number of complicated plaques increase substantially
from the ascending aorta to the aortic arch and to the descending
aorta. However, there is a relationship between the degrees of athero-
sclerosis in the thoracic and abdominal aortas, as patients with athero-
sclerotic abdominal aortic aneurysms frequently also have thoracic
aortic atherosclerosis, which is typically less severe than that present
in the abdominal aorta.
Complications of aortic atherosclerosis that may result in surgical
correction include aneurysm formation, aneurysm rupture, occlusive
aortic thrombosis, ﬁstula formation, infection, penetrating ulcer with
dissection, and distal embolization of thrombus and/or plaque material.
In surgical pathology studies of aortas resected primarily for aneurysms,
ruptured aneurysms, and dissections, the frequency and severity of
atherosclerosis aremuch greater in resected abdominal aortic segments
than in resected thoracic aortic segments [26–32]. In adults, prominent
atherosclerosis typically involves less than 10% of resected thoracic
aortic segments but usually more than 80% of resected abdominal aortic
segments.
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Inﬂammatory aortic aneurysm or IAA is a disorder identiﬁed initially
based on the intraoperative gross appearance of the aorta showing
thickening of the wall with ﬁbrosis and extensive adhesions to adjacent
structures [13,28,33–41]. So deﬁned, it has been reported to be present
in 2%–15% of resected abdominal aortic aneurysms, most often in men,
and usually in the setting of severe aortic atherosclerosis. Histologic as-
sessment of the thickened adventitia typically shows ﬁbrosis with ex-
tensive inﬂammation, most often composed of lymphocytes and
plasma cells, but less commonly, granulomatous inﬂammation, includ-
ing giant cells and occasional compact granulomas, has been reported.
There are often lymphoid follicles, as well as inﬂammation involving
small adventitial arteries and veins. Some, but not all, studies have
shown increased preoperative serum inﬂammatory markers.
The literature regarding IAA is difﬁcult to interpret. Since the condi-
tion is often deﬁned clinically or intraoperatively, these cases likely rep-
resent a mixture of diseases ranging from secondary complications of
severe atherosclerosis to primary involvement by systemic rheumato-
logic diseases. In some series, the pathologic features of inﬂammatory
aneurysm, as deﬁned intraoperatively, overlap with the pathologic fea-
tures of atherosclerosis [13,28,35,40,41]. In patients with clinically de-
ﬁned IAA, inﬂammatory markers elevated preoperatively have been
reported to normalize after repair of the aneurysm, despite the aneu-
rysm tissue not being resected. Likewise, by imaging, the periadventitial
inﬂammation and ﬁbrosis have often been reported to decrease follow-
ing either endovascular or open repair of the abdominal aortic aneu-
rysm [42,43]. These observations suggest that many patients clinically
diagnosed with IAA likely have a localized inﬂammatory response to
an atherosclerotic aneurysm.
For cases on the other end of the spectrum, IAA has often been difﬁ-
cult to distinguish from chronic periaortitis due to outright systemic
rheumatologic diseases including GCA, rheumatoid arthritis, ankylosing
spondylitis (AS), systemic lupus erythematosus (SLE), GPA, and IgG4-
RD [44–46]. Such cases of chronic periaortitis may also involve other ar-
teries, present with clinical features of autoimmune diseases, and/or be
accompanied by retroperitoneal ﬁbrosis or sclerosing mediastinitis.
4.3. Noninfectious aortitis/periaortitis
Noninfectious aortitis is deﬁned as an inﬂammatory process involv-
ing one ormore layers of the aortic wall in which the inﬂammation can-
not be accounted for by some other process such as atherosclerosis or
infection. If the inﬂammation is limited to the adventitia, then the
term periaortitis is often employed. In studies involving primarily the
thoracic aorta, noninfectious aortitis has been reported to involve
from 2% to 16% of aortic resections [26,29,30,47–55]. Aortitis is often
an unexpected diagnosis at histological examination of surgically
resected thoracic aneurysms and dissections, andmaybe the presenting
feature of a systemic vasculitis ormay occur in the absence of other clin-
ical signs or symptoms of systemic vasculitis.
In noninfectious aortitis, the aorta often shows thickening of thewall
and irregular bulging of the intima giving a gross intimal cobblestone
appearance. The normal aorta contains no inﬂammatory cells in its inti-
ma or media. However, in noninfectious aortitis, there are often lym-
phocytes and plasma cells in the adventitia singly, in aggregates, or in
germinal centers. In noninfectious aortitis, there is inﬂammation in
the media as well. In chronic periaortitis, the inﬂammation will be con-
ﬁned to the adventitia. The characteristics of the inﬂammatory inﬁltrate
are to some extent dependent on the speciﬁc type of aortitis or
periaortitis present. Inﬂammatory cells may be seen in and around the
aorta in a variety of situations that are not vasculitis. In degenerative
aortic disease, patchy mild chronic inﬂammation may be seen, often
around vasa vasorum, presumably as a consequence rather than a
cause of thedegenerative change. As noted above, chronic inﬂammation
frequently accompanies atherosclerosis. In aortic dissection, there maybe an acute inﬂammatory reaction around the dissection plane. In the
late phase, scarring can be seen in themedia with disruption and disor-
ganization of the remaining elastic ﬁbers and replacement by dense ﬁ-
brous tissue. In end-stage aortitis, there may be little inﬂammation but
prominent ﬁbrosis throughout the wall.
Speciﬁc rheumatologic diseases most commonly associated with
noninfectious aortitis are discussed below. Many additional conditions
have also been associatedwith aortitis including reactive arthritis, rheu-
matic heart disease, Kawasaki disease, Crohn’s disease, andmicroscopic
polyangiitis.
4.3.1. Giant cell arteritis
GCA (Horton’s disease) is themost common systemic vasculitis that
involves the aorta [47,49,56–61]. GCA primarily, if not exclusively, af-
fects persons older than 50 years of age. Disease susceptibility has
been associated with northern European descent, and two thirds of
those affected are women. GCA typically causes vasculitis of the extra-
cranial branches of the carotid arteries and the aorta, and often spares
intracranial vessels. Clinical symptoms reﬂect end-organ ischemia. Pre-
senting features are typically a unilateral headache, jaw claudication, or
visual impairment. GCA is associated with polymyalgia rheumatica, a
disorder characterized by severe myalgias and stiffness of the muscles
of the neck, shoulder girdle, and pelvic girdle. Additional clinical fea-
tures may include malaise, anorexia, weight loss, fever, night sweats,
depression, and elevated inﬂammatory markers, including erythrocyte
sedimentation rate (ESR), C-reactive protein, and IL-6.
GCA confers an increased risk of both thoracic and abdominal aneu-
rysms and of aortic dissection and/or rupture. Aortic involvement can
precede cranial symptoms, be in association with cranial symptoms,
or occur after the diagnosis of cranial GCA. Pathologically, the diagnosis
of GCA is most often established by a superﬁcial temporal artery biopsy.
Occasionally, aortitis is the presenting feature of a patient with subse-
quent clinically recognized systemic GCA. Histologically, aortitis due to
GCA is characterized by granulomatous inﬂammation in the media
comprised of epithelioid macrophages and occasional giant cells.
There is usually an accompanying lymphoplasmacytic inﬁltrate, which
may predominate in the adventitia. This inﬂammation is often associat-
edwith so-called “laminarmedial necrosis,” areas of smoothmuscle cell
loss with collapsed elastic ﬁbers. The vasa vasorummay also be abnor-
mally prominent in the middle and inner thirds of the medial layer.
Compact granulomas are usually absent. The inner half of the aorta
often shows more involvement than the outer half and adventitia. Inti-
mal hyperplasia is frequently present. In the later phases of the disease,
there may be extensive scarring, but the adventitia is relatively spared
compared with some other forms of aortitis, such as Takayasu arteritis.
Patients with histologic features strongly suggestive of aortic in-
volvement by GCA often manifest no other clinical signs or symptoms
for systemic GCA. Thus, the term giant cell aortitis is often used to help
distinguish these patients from thosewith clinical and/or pathologic ev-
idence of GCA with cranial involvement. Autopsy studies have shown
that pathologic systemic GCA, even with cranial involvement, is most
often an indolent condition, with the majority of cases remaining sub-
clinical during life [62]. Likewise, patients who have been previously
treated for systemic/cranial GCA and who do not have clinically appar-
ent active vasculitis can be found to have active systemic GCA patholog-
ically at autopsy [63,64].
4.3.2. Takayasu arteritis
In patients below the age of 50, Takayasu arteritis is the most com-
mon systemic vasculitis that afﬂicts the aorta [32,47,49,55,65–70].
Takayasu arteritis primarily involves large elastic arteries, particularly
the aorta and arch vessels. The coronary ostia, renal arteries, andpulmo-
nary arteries may also be involved. Clinical manifestations range from
asymptomatic disease with impalpable pulses to subclavian steal syn-
drome to catastrophic neurologic strokes. Adolescent girls and women
in their second and third decades of life are most affected. This arteritis
274 J.R. Stone et al. / Cardiovascular Pathology 24 (2015) 267–278ismost commonly seen in Japan, Southeast Asia, India, andMexico. Pan-
arteritic inﬂammatory inﬁltrates cause marked thickening of the in-
volved artery with intimal hyperplasia and subsequent luminal
narrowing and occlusion. Diffuse dilatation, formation of aneurysms,
and thrombosis can occur. The inﬂammatory and stenotic phases of
the disease frequently coexist. The acute phase is characterized by
edema and diffuse inﬂammatory inﬁltrates involving the media, the
media–intimal junction, and the adventitia, often affecting the vasa
vasorum. The inﬂammatory inﬁltrate is overall granulomatous and is
composed of macrophages with variable amounts of T- and B-
lymphocytes, plasma cells, and eosinophils. A common feature is the
presence of giant cells. Compact granulomas and medial necrosis may
be present. In the late phase of the disease, scarring can be seen in the
tunicamediawith disruption and disorganization of the remaining elas-
tic ﬁbers. Dense adventitial ﬁbrosis is often present. The intima can
show a great degree of ﬁbrous thickening, often with an overlap of
ﬁbroatheromatous plaques. These two combined features give a gross
“tree bark” appearance to the intimal surface, as in other forms of
aortitis.
The histologic pattern of Takayasu arteritis may overlap with that of
both GCA and sarcoidosis, and thus clinical–pathologic correlation is
often required. However, there are pathologic features that may help
to distinguish betweenGCA andTakayasu arteritis. Aorticwall thickness
is generally greater in Takayasu arteritis than in GCA. In addition, GCA is
more commonly associated with inﬂammation that is most severe in
the inner media, and GCA is not as often associated with the severe ad-
ventitial scarring seen in Takayasu arteritis. Compact granulomas are
more commonly seen in Takayasu arteritis than in GCA.
4.3.3. Rheumatoid arthritis
Aortitis is an uncommon extra-articular manifestation of rheuma-
toid arthritis. Rheumatoid aortitismay be associatedwith amore gener-
alized rheumatoid vasculitis, which can occur in the early stage of the
disease, but more commonly occurs in patients who have had seropos-
itive rheumatoid arthritis for 10 years or longer. Rheumatoid vasculitis
may affect blood vessels of all sizes, from small vessels of the vasa
vasorum to the aortic wall itself [71,72]. An autopsy study identiﬁed
10 cases of rheumatoid aortitis from among 188 consecutive autopsy
cases of rheumatoid arthritis [73]. A small number of rheumatoid
aortitis cases have also been identiﬁed in surgically resected aortic seg-
ments [49,54,74]. Either the thoracic or abdominal aorta may be in-
volved, and the inﬂammation may be present in all layers of the aorta
or be limited to the media. The inﬁltrate is most often predominately
composed of lymphocytes and plasma cells. A granulomatous compo-
nent to the inﬂammation can be found in many of the cases, which
may include giant cells and, in about half of the cases, actual rheumatoid
nodules, which are associated with necrosis and palisading histiocytes/
macrophages. When present, rheumatoid nodules can help to distin-
guish this disease from other forms of aortitis with a granulomatous/
giant cell pattern, such as GCA, Takayasu arteritis, and sarcoidosis.
4.3.4. Systemic lupus erythematosus
Aortitis is an uncommon complication of SLE, and most aortic aneu-
rysms in SLE are degenerative and not inﬂammatory. Most cases of
lupus-associated aortitis have been described in conjunctionwith aortic
aneurysms or aortic dissection. Histologic features have only been re-
ported in a few cases [47,50,54,75–79]. In lupus aortitis, the inﬂamma-
tory inﬁltrate is typically either lymphocytic or lymphoplasmacytic,
and not usually granulomatous. Both the adventitia and media may be
involved. There is often involvement of adventitial vessels, with ﬁbri-
noid necrosis of these vessels in some cases.
4.3.5. Ankylosing spondylitis
AS is a chronic inﬂammatory rheumatic disease of the spine (spon-
dylitis) and sacroiliac joints (sacroiliitis) associated in many cases with
inﬂammation of the peripheral joints (arthritis), eyes (uveitis), intestine(enteritis), and aortic root (aortitis). Predisposition to AS (90%) is asso-
ciated with genetic factors, the key gene of which is HLA-B27. Patients
may develop aortitis, which frequently involves the aortic root and the
ascending aorta. Aortitis can occur in both late and early phases of the
disease. The histologic features of the aortitis in AS have only been de-
scribed in a few cases [26,80,81]. The aortic root is most affected, and
the aortic valve may be involved. There is usually ﬁbrosis, which is
oftenmore pronounced in the adventitia than in themedia. The inﬂam-
mation is lymphoplasmacytic and may be restricted to the adventitia.
4.3.6. Relapsing polychondritis
This disease causes destruction of the ear and nasal cartilage as well
as scleritis. The aorta can rarely be involved, particularly the ascending
aorta. Pathologic features have only been described in a few
cases [82]. The medial elastic tissue is destroyed and replaced by vascu-
lar granulation tissue and focal necrosis. Neutrophil leukocyte aggre-
gates forming microabscesses may be present in the media and
intima. The adventitia shows lymphocytic inﬁltration and ﬁbrosis.
Giant cells, granulomas. and eosinophils are usually not present.
4.3.7. Granulomatosis with polyangiitis (formerly Wegener’s
granulomatosis)
GPA is a raremultisystem disease that has been reported to affect al-
most every organ in the body. It is characterized by a small vessel neu-
trophilic vasculitis as well as a necrotizing granulomatous process,
which may involve medium-sized and large vessels. It is often associat-
ed with the presence of anti-neutrophil cytoplasmic antibodies (ANCA)
to either myeloperoxidase or proteinase-3. Most patients present with
some evidence of respiratory tract involvement. Large-vessel involve-
mentwith aortic aneurysmor dissection has been occasionally reported
[83–86]. Both the thoracic and abdominal aorta may be involved, and
some cases present on imaging as primarily periaortitis. Histologically,
there is granulomatous inﬂammation of the media and adventitia with
geographic necrosis surrounded by palisading histiocytes and scattered
giant cells admixed with neutrophils. The giant cells are not speciﬁcally
restricted to the elastic lamellae, which is more typical of GCA. Also the
degree of necrosis and neutrophil inﬁltration is more extensive than
typically seen in GCA. Special stains to rule out infection are often
helpful.
4.3.8. Eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg
Strauss syndrome)
The histological hallmark of EGPA is a necrotizing vasculitis similar
to GPA but with a predominance of eosinophils. There may or may not
be a previous history of asthma, peripheral eosinophilia, or systemic
organ involvement. Aortic involvement is rare [87]. Histologically,
there is granulomatous inﬂammation admixedwith eosinophils. The in-
ﬂammation may be largely restricted to the adventitia.
4.3.9. Cogan syndrome
Cogan syndrome is an unusual disorder characterized by episodes of
interstitial keratitis and vestibuloauditory dysfunction (i.e., eye and ear
symptoms). Aortitis occurs in up to 10% of cases of Cogan syndrome.
Hearing loss, tinnitus, vertigo, as well as interstitial keratitis are com-
mon, but episcleritis, scleritis, or iritis has also been described. The
aortitis usually affects the ascending aorta and the arch, and is usually
due to inﬂammation with a mixed inﬂammatory pattern [88–90].
There is inﬁltration of the intima andmedia by neutrophils surrounding
areas of medial necrosis with focal transmural destruction of the wall.
Macrophages are also prominent, with very occasional giant cells
noted in the necrotic areas of themedia. An overtly granulomatous pat-
tern of inﬂammation is not usually present.
4.3.10. Behçet’s disease
Behçet’s disease is characterized clinically by genital ulceration, oral
ulcers (aphthous stomatitis), and uveitis. Vascular involvement can
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tion. Aortitis may be present, in some cases associated with aortic valve
regurgitation [91,92]. Histologically, the inﬂammation in Behçet’s dis-
ease typically shows a mixed pattern, being composed of most, if not
all, cell types, without being overtly granulomatous. Histologic features
of the aortitis in Behçet’s disease have been reported in only a few
cases [93].
4.3.11. Sarcoidosis
Sarcoidosis is a systemic disorder characterized by granulomatous
inﬂammation usually containing non-necrotizing granulomas, which
primarily involves the lungs, lymph nodes, and skin. The pathology of
aortic involvement by sarcoidosis has only been reported in a small
number of cases [94–98]. The features of the inﬂammatory inﬁltrate
are consistent with those of sarcoidosis in other parts of the body.
There is granulomatous inﬂammation including compact noncaseating
granulomas and giant cells. There is usually an accompanying lympho-
cytic or lymphoplasmacytic inﬁltrate. In some cases, only a lymphocytic
inﬁltrate is identiﬁed. The inﬂammationmay involve the intima, media,
and/or adventitia. The inﬂammationmay be limited to the adventitia as
a periaortitis. Sarcoidosis may involve either the thoracic or abdominal
aorta, and may be seen in both younger and older patients.
4.3.12. IgG4-related disease
IgG4-RD is a recently recognized disease thatmay be associatedwith
aortitis or periaortitis [31,32,41,52,53,99]. IgG4-RD is characterized by
elevated serum levels of IgG4 and histopathological ﬁndings including
ﬁbrosis and prominent tissue inﬁltration by lymphocytes and IgG4-
positive plasma cells. The disorder was ﬁrst recognized in the pancreas
as a form of autoimmune pancreatitis. Subsequently, numerous
extrapancreatic lesions have been described in this disorder including
sialadenitis, lacrimal gland inﬂammation, lymphadenopathy, aortitis/
periaortitis, sclerosing cholangitis, tubulointerstitial nephritis, retroper-
itoneal ﬁbrosis, and inﬂammatory pseudotumors. Multiorgan lesions
can occur synchronously or metachronously in the same patient. The
disease usually afﬂicts older individuals after 50 years of age. IgG4-RD
may result in acute events due to aortic dissection or aneurysm rupture
[99–101]. The vasculitis of IgG4-RDmay also involve large andmedium-
sized arterial branches of the aorta [101–103].
IgG4-RD can either result in lymphoplasmacytic aortitis or be re-
stricted to the adventitia as a periaortitis. The principal histopathologic
ﬁndings are lymphoplasmacytic inﬁltration, lymphoid follicle forma-
tion, obliterative adventitial phlebitis, and ﬁbrosis, which may have a
storiform pattern. A modest tissue eosinophilia is reported in some
but not all cases, most commonly in the abdominal aorta. International
consensus guidelines for the pathologic diagnosis of IgG4-related
aortitis/periaortitis require the presence of a lymphoplasmacytic
aortitis/periaortitis with more than 50 IgG4+ plasma cells per 400×
HPF and an IgG4/IgG ratio greater than 50%, when counting the three
HPFs with the highest degree of IgG4 positivity [104]. Other conditions
such as infection must also be excluded [105]. Granulomatous inﬂam-
mation and suppurative inﬂammation are not components of this dis-
ease, although neutrophils may be present if there is a coexisting
recent aortic rupture or dissection. When these guidelines are applied,
IgG4-RD has been found to account for 9%–22% of thoracic aortitis
cases [32,52,53]. IgG4-related periaortitis has been reported to be pres-
ent pathologically in around half of patients with inﬂammatory abdom-
inal aortic aneurysm [31,41], although uncertainty exists in
differentiating systemic IgG4-RD froma localized reaction to atheroscle-
rosis in this setting [46].
4.3.13. Clinically isolated aortitis
In some patientswith pathologic aortitis in resected aortic segments,
there is no clear clinical evidence of a systemic rheumatologic disease to
account for the vasculitis, and the aortitis is referred to as “isolated” or
“idiopathic.” The frequency of this phenomenon ranges from 0% to100% of thoracic aortitis cases in different series, with some of the vari-
ability likely being due to variations in patient demographics and the
thoroughness of the clinical workup [26,41,47–49,51,54,90,106–108].
Such clinically isolated aortitis is encounteredmost commonly in the as-
cending aorta. Since this grouping of patients is through clinical fea-
tures, there is no speciﬁc pattern of inﬂammation to deﬁne this
proposed subgroup of aortitis. The inﬂammation is most often granulo-
matous and indistinguishable from that of GCA, but the inﬂammation
may be purely lymphoplasmacytic and, by routine slides, indistinguish-
able from that of IgG4-RD. This group of patients includes both younger
adults and older adults, although like noninfectious aortitis in general,
the patients tend to be older.
Studies speciﬁcally focusing on the long-term follow-up of ascend-
ing aortitis in the absence of clinical evidence of systemic vasculitis are
limited. One report has suggested that patients with clinically isolated
aortitis are not at an increased risk for subsequent adverse events
such as distal aortic aneurysms and dissections [49]. However, a subse-
quent report suggested that, on imaging, these patients frequently have
concurrent aneurysms at additional sites throughout the body at the
time of initial aortic surgery [51]. In a recent case–control study with
long-term follow-up, including in most cases aortic imaging, patients
with a giant cell aortitis pattern of inﬂammation in the ascending
aorta but lacking clinical evidence of systemic vasculitis had a statistical-
ly signiﬁcant higher rate of subsequent distal aortic aneurysms and dis-
sections as compared with a matched control group [109].
Currently, it is unclear if clinically isolated aortitis is a distinct path-
ologic entity or a heterogeneous group of aortitis subtypes being
lumped together based on clinical presentation. It is also not clear if
the majority of these cases truly have a vasculitis that is pathologically
completely isolated to a discrete aortic segment or if the vasculitis is sys-
temic but largely subclinical. In a large autopsy study, 13 cases of nonin-
fectious ascending aortitis were identiﬁed in older patients (mean age
81 years, range 62–96 years) [62]. Of these 13 cases, 12 (92%) had path-
ologic involvement of the temporal arteries by vasculitis, despite the
fact that at least 10 (77%) of the patients lacked clinical evidence of sys-
temic vasculitis before death. Furthermore, as our understanding of the
speciﬁc types of aortitis continues to grow, it is also becoming clear that
vasculitis in newly recognized systemic diseases, such as IgG4-RD, have
in some cases previously been assumed to be isolated to the aorta based
on clinical grounds [46]. More studies will be required to clarify our un-
derstanding on this issue.
While periaortitis may be due to some of the systemic disorders
listed above, chronic periaortitis can be present without clinical evi-
dence of systemic vasculitis, particularly in the abdominal aorta
[44–46]. This, again, likely represents a heterogeneous group of condi-
tions andmay be associated with a more generalized retroperitoneal ﬁ-
brosis in some patients. Chronic abdominal periaortitis usually occurs in
the setting of severe aortic atherosclerosis, and in many cases, it may
represent a localized reaction to atherosclerosis. Some authors have
used the term chronic periaortitis almost synonymously with the term
inﬂammatory aortic aneurysm.
4.4. Infectious aortitis
Atherosclerotic and systemic arterial hypertensive diseases are the
most common (and important) etiologies of aortic aneurysmal disease.
Elsewhere in these recommendations, the less frequent noninfectious
aortitides are also discussed. Occurring with a substantially lesser fre-
quency (at least in industrialized nations) are the infectious causes of
aortic aneurysmal disease, including luetic and tuberculous forms.
4.4.1. Suppurative/mycotic infectious aortitis
Infectious aortitis can develop secondary to embolization of a septic
embolus, typically as a complication of infective endocarditis. Osler used
the termmycotic aneurysm to describe aneurysms associatedwith infec-
tive endocarditis, referring to the “mushrooming” appearance of the
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these are bacterial in nature, mostly arising from endocarditic vegeta-
tions initially embolizing to vessels of the vasa vasorum. Infectious
aortitis may also develop by direct extension of an adjacent infectious
process (e.g., from the esophagus, lung, or pericardium) or through di-
rect vascular infection by circulating organisms, usually initiating as a
nidus in the vasa vasorum or on the luminal surface of an ulcerated ath-
erosclerotic plaque.
Lesions typically arise in areas of preexisting vascular dilation
(e.g., due to systemic arterial hypertension) or injury (e.g., surgical or in-
vasive monitoring), or in a preexisting atheromatous plaque. Immune
compromise (e.g., due to diabetes mellitus, glucocorticoids, chemother-
apy, and/or malignancy) is also an important risk factor. Antecedent in-
fection (e.g., pneumonia, cholecystitis, urinary tract infection) can be
identiﬁed in roughly half of cases, and half of these (25% overall) are at-
tributable to infective endocarditis. Infectious aneurysms of the thoracic
aorta are relatively rare and most commonly result from direct exten-
sion of a mediastinal infection or involvement of the aortic root by an
aggressive infective endocarditis.
Patients typically present with fever and a rapidly enlarging, painful
(back or abdominal pain) pulsatilemass. There is generally leukocytosis,
and the ESR may be elevated. Imaging will typically demonstrate aneu-
rysm formation, which may be multifocal, particularly in the setting of
embolization of infective endocarditis lesions. Soft tissue inﬂammation
adjacent to the lesion or perivascular ﬂuid collections raises the suspi-
cion of an infectious aneurysm. Blood cultures are positive in 50%–85%
of cases, with Staphylococcus and Salmonella species being most com-
mon. Streptococcus pneumoniae and other non-Salmonella Gram-
negative bacilli are also etiologic agents. Fungi are considerably less
common, except in speciﬁc situations such as immune compromise or
associated with broad-spectrum antibacterial treatment.
Histology will reveal transmural inﬂammation, which is primarily
acute rather than chronic, with abscesses containing numerous neutro-
phils and variable degrees of necrosis and thrombosis [104,110]. Evi-
dence of incipient or frank vascular rupture is also often present.
Microbial stains (Gram or silver) are usually manifestly positive. Al-
though prior antimicrobial therapy may reduce bacterial wall staining
by Gram stain, silver stains will still typically reveal bacteria, albeit
with some expansion and central clearing due to antibiotic effects.
Distinguishing infected aneurysms versus noninfectious inﬂamma-
tory aneurysms is not usually difﬁcult. In addition to the presence or ab-
sence of microbes (as demonstrated by cultures and/or staining),
infected aneurysmswill have amore dense transmural acute inﬂamma-
tory response, while noninfectious inﬂammatory aneurysms are
marked by more severe chronic inﬂammation and adventitial ﬁbrosis.
Perioperative mortality for infectious aortic aneurysms is 15%–20%,
with worse outcomes in the setting of Gram-negative infections and/
or ruptures.
4.4.2. Syphilitic aortitis
Syphilitic aneurysms develop as a manifestation of tertiary syphilis
[111,112] and currently represent an exceedingly rare cause of aortic
aneurysms. As opposed to the other more common infectious aneu-
rysms described above, luetic aortitis more commonly affects the as-
cending and thoracic aorta. The obliterative endarteritis characteristic
of tertiary syphilis shows a predilection for the vessels of the vasa
vasorum, leading to ischemic injury of the aortic media and aneurysmal
dilation that can include the aortic valve annulus with presentation as
aortic valvular insufﬁciency. Indeed, the dilated valvular annulus and
accompanying chronic valvular insufﬁciency can lead tomassive cardiac
enlargement and the classic “cor bovinum” (cow’s heart) with heart
weights in excess of a kilogram. Congestive cardiac failure in the setting
of such chronic overload failure is the most common cause of death in
these patients. The coronary ostia may also be involved, leading to car-
diac ischemia. Imaging studies will classically demonstrate prominent
ascending aorta aneurysm formation.The predilection of the causal spirochetes for the small vessels of the
vasa vasorum leads to adventitial chronic inﬂammation, particularly in-
volving the small arteries and arterioles that perfuse themedia. The en-
suing immune response to the microbe causes direct vascular damage;
there are luminal narrowing and obliteration (obliterative endarteritis),
a dense surrounding rim of lymphocytes, and especially plasma cells
that may extend into the media, with associated adventitial ﬁbrosis.
Focal areas of necrosis surrounded by palisadingmacrophages, often re-
ferred to as “microgummas,” may also be present. The spirochetes are
difﬁcult if not impossible to demonstrate in these aneurysms.
In patients without prior known history of syphilis, the histologic
ﬁndings may merit additional conﬁrmation with serologic studies. Al-
though rapid plasma reagin and Venereal Disease Research Laboratory
tests have good sensitivity for tertiary syphilis (~95%), ﬂuorescent trep-
onemal antibody studies have almost 100% sensitivity.
The obliteration of the vasa vasorum results in aortic medial ische-
mic injury, with variable loss of smoothmuscle cells and associatedma-
trix. With medial destruction, elastic recoil is lost, and the aorta
becomes dilated to produce an aneurysm. Subsequent medial scar con-
traction can “wrinkle” the intervening segments of aorta. With
superimposed atherosclerotic plaque, such intimal lesions grossly re-
semble “tree bark.”
4.4.3. Mycobacterial aortitis
Tuberculous aneurysms are exceedingly rare causes of infected an-
eurysms in developed countries; one study describes only 41 cases be-
tween 1945 and 1999 [113]. However, the condition may be more
frequently encountered in less developed countries. These are most
often attributable (75% of cases) to erosion of infected periaortic
lymphnodes or other infected foci into the adjacent aorticwall. The tho-
racic and abdominal aortic regions are equally affected. Roughly half of
patients have disseminated tuberculosis. Aortic involvement typically
ranges frommiliary tuberculosis of the intima to transmural tuberculo-
sis and to aneurysm formation. Complications can also include ﬁstula
formation and, rarely, coronary artery ostial obstruction [114]. Although
most lesions show characteristic granulomatous lesions (with or with-
out central caseation and organisms identiﬁable by acid-fast bacillus
staining), there are reports of ﬁbrotic lesions attributable to hypersensi-
tivity responses. Untreated, the tuberculous aortitis is almost uniformly
fatalwith death often due to aneurysmrupture. However, combined an-
tibiotic and surgical therapy substantially improves survival. Abdominal
mycobacterial aortitis may in rare cases also result fromMycobacterium
bovis in the setting of intravesical bacillus Calmette–Guérin therapy for
bladder cancer [115].
5. Discussion
These consensus criteria offer a ﬁrst global approach to the general
subclassiﬁcation of inﬂammatory aortic diseases based on histologic
features. It is acknowledged that there are some areas that remain difﬁ-
cult and controversial, such as the distinction between IAA and
periaortitis. It is also acknowledged that, for some pathologists, these
criteria will require a change in the manner in which certain diagnostic
terms are employed.
One example is the use of the word granulomatous. The committee
agreed to adopt the more general deﬁnition of this term, applying it to
lesions that contain clusters of epithelioid macrophages in general and
not restricting the use of the word to only lesions that contain
compact/well-formed granulomas and/or giant cells. This is consistent
with the current use of the term in general surgical pathology practice
in many centers.
While the criteria provided here offer a mechanism for the initial
classiﬁcation of an aortitis based on the pattern of inﬂammation, deﬁn-
itive subclassiﬁcation of the speciﬁc disease processes is often not
achievable based solely on histologic features. A major limitation is
that, for many of the diseases discussed, the published literature
277J.R. Stone et al. / Cardiovascular Pathology 24 (2015) 267–278concerning the histologic features is limited to a handful of case reports.
Another limitation is the variable and sometimes nonspeciﬁc fashion in
which clinical subclassiﬁcations are rendered in patients with aortitis,
with, for example, the designation of Takayasu arteritis being applied
to essentially all patients with aortitis under the age of 50 in some cen-
ters. It is also recognized that with the exception of IgG4, there are few
tissue markers that have been demonstrated to subclassify the inﬂam-
matory inﬁltrates in a clinically useful manner. It is clear that for prog-
ress to be made in identifying the distinctive pathology of these
conditions, more studies with larger numbers of patients utilizing
novel tissue markers will need to be completed.
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